Early research (Phase 1)Study completedNCT05978713What this trial is testingTirzepatide (LY3298176) in Healthy Lactating FemalesWho this might be right forHealthy Eli Lilly and Company 11
Not applicableNot Yet RecruitingNCT07567378What this trial is testingCARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational RegistryWho this might be right forPsoriatic ArthritisOsteoarthitisKnee+12 more JULIO GRANADOS MONTIEL 30
Post-approval studies (Phase 4)Looking for participantsNCT06901245What this trial is testingTirzepatide in PWS, HO and GNSOWho this might be right forPrader-Willi SyndromeHypothalamic ObesityObesity/Therapy Grace Kim 36
Post-approval studies (Phase 4)Looking for participantsNCT06657209What this trial is testingNormal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or TirzepatideWho this might be right forDiabetes Mellitus, Type 2DiabetesType 2 Diabetes+1 more Stanford University 104
Not applicableActive Not RecruitingNCT06980623What this trial is testingComparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection FractionWho this might be right forType 2 DiabetesHeart Failure Brigham and Women's Hospital 26,000
Testing effectiveness (Phase 2)Looking for participantsNCT07245771What this trial is testingPhase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and ObesityWho this might be right forObesity &Amp; Overweight Ikaria Bioscience Pty Ltd 104
Testing effectiveness (Phase 2)Looking for participantsNCT05912621What this trial is testingTirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/ObesityWho this might be right forObesityOverweight and ObesityOverweight Stanford University 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06737042What this trial is testingEfficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight ParticipantsWho this might be right forObesity and Overweight Gan and Lee Pharmaceuticals, USA 285
Very early researchLooking for participantsNCT06734273What this trial is testingRandomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight LossWho this might be right forObesity and Obesity-related Medical Conditions Nicholas Skertich 42
Testing effectiveness (Phase 2)Looking for participantsNCT07220473What this trial is testingTirzepatide to Slow Biological AgingWho this might be right forAgingLONGEVITY 1 The University of Texas Medical Branch, Galveston 90
Testing effectiveness (Phase 2)Looking for participantsNCT06517212What this trial is testingTirzepatide Weight Loss for MRD+ Early Breast CancerWho this might be right forBreast CancerBreast NeoplasmsBreast Cancers Baylor Research Institute 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07555730What this trial is testingAI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)Who this might be right forOverweight or Obesity; Type 2 DiabetesWeight Loss Maintenance Huazhong University of Science and Technology 400
Large-scale testing (Phase 3)Looking for participantsNCT06439277What this trial is testingTirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)Who this might be right forObesityWeight Gain Eli Lilly and Company 300
Large-scale testing (Phase 3)Study completedNCT05024032What this trial is testingTirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)Who this might be right forObesityOverweightMetabolism and Nutrition Disorder Eli Lilly and Company 210
Large-scale testing (Phase 3)Looking for participantsNCT07284511What this trial is testingA Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarWho this might be right forType 1 DiabetesType 1 Diabetes MellitusT1D+2 more McGill University Health Centre/Research Institute of the McGill University Health Centre 105
Testing effectiveness (Phase 2)Looking for participantsNCT06897475What this trial is testingLY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideWho this might be right forType 2 Diabetes Eli Lilly and Company 240
Post-approval studies (Phase 4)Study completedNCT05564039What this trial is testingTirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)Who this might be right forType 2 Diabetes Eli Lilly and Company 282
Post-approval studies (Phase 4)Looking for participantsNCT07096908What this trial is testingTirzepatide Use in People With Obesity and Type 1 DiabetesWho this might be right forType1diabetesObesity Dasman Diabetes Institute 60
Not applicableLooking for participantsNCT07589322What this trial is testingComparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTsWho this might be right forObesity and Metabolic Syndrome Tri-Service General Hospital 120
Large-scale testing (Phase 3)Study completedNCT03882970What this trial is testingTirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus Eli Lilly and Company 1,444